DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

FDA Device Recall #Z-0779-2017 — Class III — November 16, 2016

Recall Summary

Recall Number Z-0779-2017
Classification Class III — Low risk
Date Initiated November 16, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm PerkinElmer Health Sciences, Inc.
Location Waltham, MA
Product Type Devices
Quantity 79 kits

Product Description

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

Reason for Recall

A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76  67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.

Distribution Pattern

CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,

Lot / Code Information

Lot Number: 646091

Other Recalls from PerkinElmer Health Sciences, Inc.

Recall # Classification Product Date
Z-2264-2020 Class III PerkinElmer 226 Sample Collection Device Dec 19, 2017
Z-2756-2017 Class III PerkinElmer 226 Sample Collection Device The... May 31, 2017
Z-1101-2017 Class III Program Update Package AutoDELFIA¿ 3.0, Fluorom... Dec 21, 2016
Z-1102-2017 Class III DELFIA¿ PC with V3.0 Software, Fluorometer, for... Dec 21, 2016
Z-1100-2017 Class III AutoDELFIA¿ Plate Processor , Fluorometer, for... Dec 21, 2016

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.